Full CoverageWasted miracle? Concerns as revolutionary HIV drug approved
By Matthew Ward
Top news
Uptake of Gilead's Yeztugo will be swift, analyst says after discussion with HIV doc
By Kevin Dunleavy
Regulators Approve a Twice-Yearly Shot to Prevent H.I.V. Infection
By Apoorva Mandavilli
The FDA Just Approved a Long-Lasting Injection to Prevent HIV
By Jorge Garay
The Drug That Could Revolutionize the Fight Against H.I.V.
By Jon Cohen
All coverage
A University of Utah doctor’s research led to a major HIV drug. He worries federal cuts will stop people from getting it.
By Brock Marchant
The world's only twice-a-year shot to prevent HIV could stop transmission — if people can get it
By Lauran Neergaard
HIV prevention drug hailed as a 'breakthrough' gets FDA approval : Goats and Soda
By Jonathan Lambert
Coverage questions mute enthusiasm for HIV drug approval
By Natalia Gurevich & Kevin N Hume
Cost Will Be Massive Barrier in Access to Lenacapavir After Approval in the US: Gordon Crofoot, MD, PA
By Julia Bonavitacola
Here’s what everyone should know about this new HIV prevention shot
By Teddy Amenabar & Richard Sima
With Lenacapavir 'You've Basically Got a Vaccine.' But Reaching the People Who Would Benefit Is Difficult, Says Gates Foundation Expert
By Logan Lutton & Peter Wehrwein
Access Granted: Mistr Users Now Have Access to Lenacapavir
By Jasmine Franklin
Aliveness Project to offer newly approved, first-of-its-kind HIV prevention treatment
By Samantha Fischer
Another tool in the fight against HIV — and more
By Lourdes Duarte, Patrick Elwood & Katharin Czink
FDA approves twice-yearly injectable for HIV prevention; local agency weighs in on impact in the Pine Belt
By Jay Harrison
6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV
By Laura Santhanam
FDA approves new HIV prevention drug
By Candice Bruce
US FDA approves Gilead's twice-yearly injection for HIV prevention
By Deena Beasley & Julie Steenhuysen
Groundbreaking twice-a-year HIV drug that could stop transmission approved
By Lauran Neergaard
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option
By Annika Kim Constantino
FDA approves new twice-yearly HIV shot. What to know
By Ken Alltucker
FDA approves twice-a-year injection for HIV prevention
By Jacqueline Howard
FDA Approves “Breakthrough” HIV Drug
By Jackie Flynn Mogensen